- €308.88m
- €299.44m
- €316.32m
- 82
- 42
- 93
- 87
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.72 | ||
| PEG Ratio (f) | 0.81 | ||
| EPS Growth (f) | 36.63% | ||
| Dividend Yield (f) | 3.18% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.38 | ||
| Price to Tang. Book | 6.11 | ||
| Price to Free Cashflow | 17.23 | ||
| Price to Sales | 1.08 | ||
| EV to EBITDA | 15.99 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.15% | ||
| Return on Equity | 8.68% | ||
| Operating Margin | 4.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 77.22 | 159.59 | 314.61 | 285.29 | 316.32 | 338.57 | 368.23 | 37.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +41.35 | -34.23 | +23.85 | -51.56 | +122.49 | +48.76 | +27.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
M1 Kliniken AG, formerly M1 Beauty AG, is a Germany-based operator of healthcare facilities and provider of related services. The Company operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. It operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 1st, 2007
- Public Since
- September 14th, 2015
- No. of Employees
- 174
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
XETRA- Shares in Issue
- 19,125,919
- Address
- Gruenauer Strasse 5, BERLIN, 12557
- Web
- https://www.m1-kliniken.de/
- Phone
- +49 30347474414
- Auditors
- Dipl.-Kfm. Harry Haseloff, Wirtschaftspruefer
Upcoming Events for M12
Dividend For M12.DE - 0.5000 EUR
Q2 2024 M1 Kliniken AG Earnings Release
Q3 2024 M1 Kliniken AG Earnings Release
Similar to M12
FAQ
What is the M1 Kliniken AG share price?
As of Today at 15:54 UTC, shares in M1 Kliniken AG are trading at €17.85. This share price information is delayed by 15 minutes.
How has the M1 Kliniken AG share price performed this year?
Shares in M1 Kliniken AG last closed at €17.85 and the price had moved by +135.49% over the past 365 days. In terms of relative price strength the M1 Kliniken AG share price has outperformed the FTSE Global All Cap Index by +107.09% over the past year.
What are the analyst and broker recommendations for M1 Kliniken AG?
The overall consensus recommendation for M1 Kliniken AG is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the M1 Kliniken AG dividend yield?
The M1 Kliniken AG dividend yield is 2.8% based on the trailing twelve month period.
Does M1 Kliniken AG pay a dividend?
Last year, M1 Kliniken AG paid a total dividend of €0.50, and it currently has a trailing dividend yield of 2.8%.Looking ahead, shares in M1 Kliniken AG are due to go ex-dividend on 2024-07-18 and the next dividend pay date is 2024-07-22.
When does M1 Kliniken AG next pay dividends?
M1 Kliniken AG are due to go ex-dividend on 2024-07-18 and the next dividend pay date is 2024-07-22. The historic dividend yield on M1 Kliniken AG shares is currently 2.8%.
How do I buy M1 Kliniken AG shares?
To buy shares in M1 Kliniken AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of M1 Kliniken AG?
As of the previous close price of €17.85, shares in M1 Kliniken AG had a market capitalisation of €341.40m.
Where are M1 Kliniken AG shares listed?
Here are the trading details for M1 Kliniken AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: M12
What kind of share is M1 Kliniken AG?
Based on an overall assessment of its quality, value and momentum M1 Kliniken AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a M1 Kliniken AG share price forecast for 2024?
The analyst consensus target price for shares in M1 Kliniken AG is €26.70. That is 49.58% above the last closing price of €17.85.
Analysts covering M1 Kliniken AG currently have a consensus Earnings Per Share (EPS) forecast of €0.73 for the next financial year.
What is the trend in the M1 Kliniken AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like M1 Kliniken AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +53.28%.
As of the last closing price of €17.85, shares in M1 Kliniken AG were trading +44.36% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the M1 Kliniken AG PE Ratio?
The M1 Kliniken AG PE ratio based on its reported earnings over the past 12 months is 21.72. The shares last closed at €17.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of M1 Kliniken AG?
M1 Kliniken AG's management team is headed by:
- Albert Wahl - CSU
- Uwe Zimdars - VSU
- Walter von Horstig - MGB
- Sabine Meck - SUB